It is a pharma private limited company based in Ghaziabad, Uttar Pradesh, India, established in 2012.
2012 | Ghaziabad, Uttar Pradesh, India | ActivePeelife Pharmaceuticals Private Limited, a active private limited company, was established on 04 April 2012 in Ghaziabad, Uttar Pradesh, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U74120UP2012PTC049730. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹0.50 M.
It upholds a compliant status. Its leadership includes Beenu Jain (Director), Ujjawal Garg (Director), Mohit Saini (Director). Past directors included Beenu Jain, Mudit Gupta, Shobhit Gupta. It holds no open charges and ₹1.50 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at S/O Suresh Garg, Sec 63A, Ghaziabad, Uttar Pradesh, 201002.
U74120UP2012PTC049730
049730
04 April 2012
₹2.50 M
₹0.50 M
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Peelife Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Beenu Jain | Director | 05 May 2023 | Current |
| Ujjawal Garg | Director | 11 Apr 2023 | Current |
| Mohit Saini | Director | 05 May 2023 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 30 Mar 2018 | Past |
| Pramod Abcsdd | Director | 03 Jul 2023 | Past |
| Pramod Abcsdd | Director | 03 Jul 2023 | Past |
| Pramod Abcsdd | Director | 30 Mar 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Peelife Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 74.37% decrease. The company also saw a substantial fall in profitability, with a 62.26% decrease in profit. The company's net worth observed a substantial decline by a decrease of 17.25%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Peelife Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹15,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Mar 2013 | Hdfc Bank Limited | ₹1.50 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Peelife Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Peelife Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Peelife Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Peelife Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Peelife Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur. was documented.
A charge registered on 12 Mar 2013 via Charge ID 10424617 with Hdfc Bank Limited was fully satisfied on 03 Feb 2024. was recorded as a recent event.
Beenu Jain was appointed as a Director was appointed as a Director on 05 May 2023 & has been associated with this company since 2 years 7 months . was recorded as a recent event.
Mohit Saini was appointed as a Director was appointed as a Director on 05 May 2023 & has been associated with this company since 2 years 7 months . was recorded as a recent event.
Progress on Ujjawal Garg was appointed as a Director was appointed as a Director on 11 Apr 2023 & has been associated with this company since 2 years 8 months . was documented.
The CIN of Peelife Pharmaceuticals Private Limited is U74120UP2012PTC049730.
Peelife Pharmaceuticals Private Limited is headquartered at S/O Suresh Garg, Sec 63A, Ghaziabad, Uttar Pradesh, 201002.
Peelife Pharmaceuticals Private Limited was incorporated on 04 April 2012.
The current directors of Peelife Pharmaceuticals Private Limited are
The primary industry of Peelife Pharmaceuticals Private Limited is Pharma.
Peelife Pharmaceuticals Private Limited is unlisted.
The authorized capital of Peelife Pharmaceuticals Private Limited is ₹2.50 M, and the paid-up capital is ₹0.50 M.
The compliance status of Peelife Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX